Market Analysis and Insights: Global Recombinant Humanized Collagen Market
Due to the COVID-19 pandemic, the global Recombinant Humanized Collagen market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Type I Collagen accounting for % of the Recombinant Humanized Collagen global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Food Health Care segment is altered to an % CAGR throughout this forecast period.
China Recombinant Humanized Collagen market size is valued at US$ million in 2021, while the US and Europe Recombinant Humanized Collagen are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Recombinant Humanized Collagen landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Recombinant Humanized Collagen include ACROBiosystems, FineTest, Evonik, Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology and JY-RAN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Type I Collagen
Type Ⅲ Collagen
Others
Segment by Application
Food Health Care
Beauty Cosmetics
Biomedical Materials
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Recombinant Humanized Collagen market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
ACROBiosystems
FineTest
Evonik
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
JY-RAN
1 Study Coverage
1.1 Recombinant Humanized Collagen Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Humanized Collagen Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type I Collagen
1.2.3 Type Ⅲ Collagen
1.2.4 Others
1.3 Market by Application
1.3.1 Global Recombinant Humanized Collagen Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Food Health Care
1.3.3 Beauty Cosmetics
1.3.4 Biomedical Materials
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Humanized Collagen Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Humanized Collagen Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Humanized Collagen Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Humanized Collagen Sales by Region
2.4.1 Global Recombinant Humanized Collagen Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Humanized Collagen by Region (2023-2028)
2.5 Global Recombinant Humanized Collagen Revenue by Region
2.5.1 Global Recombinant Humanized Collagen Revenue by Region (2017-2022)
2.5.2 Global Recombinant Humanized Collagen Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Humanized Collagen Sales by Manufacturers
3.1.1 Global Top Recombinant Humanized Collagen Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Humanized Collagen Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Humanized Collagen in 2021
3.2 Global Recombinant Humanized Collagen Revenue by Manufacturers
3.2.1 Global Recombinant Humanized Collagen Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Humanized Collagen Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Humanized Collagen Revenue in 2021
3.3 Global Recombinant Humanized Collagen Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Humanized Collagen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Humanized Collagen Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Humanized Collagen Sales by Type
4.1.1 Global Recombinant Humanized Collagen Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Humanized Collagen Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Humanized Collagen Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Humanized Collagen Revenue by Type
4.2.1 Global Recombinant Humanized Collagen Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Humanized Collagen Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Humanized Collagen Price by Type
4.3.1 Global Recombinant Humanized Collagen Price by Type (2017-2022)
4.3.2 Global Recombinant Humanized Collagen Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Humanized Collagen Sales by Application
5.1.1 Global Recombinant Humanized Collagen Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Humanized Collagen Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Humanized Collagen Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Humanized Collagen Revenue by Application
5.2.1 Global Recombinant Humanized Collagen Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Humanized Collagen Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Humanized Collagen Price by Application
5.3.1 Global Recombinant Humanized Collagen Price by Application (2017-2022)
5.3.2 Global Recombinant Humanized Collagen Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Humanized Collagen Market Size by Type
6.1.1 North America Recombinant Humanized Collagen Sales by Type (2017-2028)
6.1.2 North America Recombinant Humanized Collagen Revenue by Type (2017-2028)
6.2 North America Recombinant Humanized Collagen Market Size by Application
6.2.1 North America Recombinant Humanized Collagen Sales by Application (2017-2028)
6.2.2 North America Recombinant Humanized Collagen Revenue by Application (2017-2028)
6.3 North America Recombinant Humanized Collagen Market Size by Country
6.3.1 North America Recombinant Humanized Collagen Sales by Country (2017-2028)
6.3.2 North America Recombinant Humanized Collagen Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Humanized Collagen Market Size by Type
7.1.1 Europe Recombinant Humanized Collagen Sales by Type (2017-2028)
7.1.2 Europe Recombinant Humanized Collagen Revenue by Type (2017-2028)
7.2 Europe Recombinant Humanized Collagen Market Size by Application
7.2.1 Europe Recombinant Humanized Collagen Sales by Application (2017-2028)
7.2.2 Europe Recombinant Humanized Collagen Revenue by Application (2017-2028)
7.3 Europe Recombinant Humanized Collagen Market Size by Country
7.3.1 Europe Recombinant Humanized Collagen Sales by Country (2017-2028)
7.3.2 Europe Recombinant Humanized Collagen Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Humanized Collagen Market Size by Type
8.1.1 Asia Pacific Recombinant Humanized Collagen Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Humanized Collagen Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Humanized Collagen Market Size by Application
8.2.1 Asia Pacific Recombinant Humanized Collagen Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Humanized Collagen Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Humanized Collagen Market Size by Region
8.3.1 Asia Pacific Recombinant Humanized Collagen Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Humanized Collagen Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Recombinant Humanized Collagen Market Size by Type
9.1.1 Latin America Recombinant Humanized Collagen Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Humanized Collagen Revenue by Type (2017-2028)
9.2 Latin America Recombinant Humanized Collagen Market Size by Application
9.2.1 Latin America Recombinant Humanized Collagen Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Humanized Collagen Revenue by Application (2017-2028)
9.3 Latin America Recombinant Humanized Collagen Market Size by Country
9.3.1 Latin America Recombinant Humanized Collagen Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Humanized Collagen Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Humanized Collagen Market Size by Type
10.1.1 Middle East and Africa Recombinant Humanized Collagen Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Humanized Collagen Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Humanized Collagen Market Size by Application
10.2.1 Middle East and Africa Recombinant Humanized Collagen Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Humanized Collagen Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Humanized Collagen Market Size by Country
10.3.1 Middle East and Africa Recombinant Humanized Collagen Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Humanized Collagen Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ACROBiosystems
11.1.1 ACROBiosystems Corporation Information
11.1.2 ACROBiosystems Overview
11.1.3 ACROBiosystems Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ACROBiosystems Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ACROBiosystems Recent Developments
11.2 FineTest
11.2.1 FineTest Corporation Information
11.2.2 FineTest Overview
11.2.3 FineTest Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 FineTest Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 FineTest Recent Developments
11.3 Evonik
11.3.1 Evonik Corporation Information
11.3.2 Evonik Overview
11.3.3 Evonik Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Evonik Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Evonik Recent Developments
11.4 Giant Biogene
11.4.1 Giant Biogene Corporation Information
11.4.2 Giant Biogene Overview
11.4.3 Giant Biogene Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Giant Biogene Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Giant Biogene Recent Developments
11.5 Shanxi Jinbo Bio-Pharmaceutical
11.5.1 Shanxi Jinbo Bio-Pharmaceutical Corporation Information
11.5.2 Shanxi Jinbo Bio-Pharmaceutical Overview
11.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
11.6 Jiangsu JLand Biotech
11.6.1 Jiangsu JLand Biotech Corporation Information
11.6.2 Jiangsu JLand Biotech Overview
11.6.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangsu JLand Biotech Recent Developments
11.7 Jiangsu Chuangjian Medical Technology
11.7.1 Jiangsu Chuangjian Medical Technology Corporation Information
11.7.2 Jiangsu Chuangjian Medical Technology Overview
11.7.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Chuangjian Medical Technology Recent Developments
11.8 JY-RAN
11.8.1 JY-RAN Corporation Information
11.8.2 JY-RAN Overview
11.8.3 JY-RAN Recombinant Humanized Collagen Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 JY-RAN Recombinant Humanized Collagen Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 JY-RAN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Humanized Collagen Industry Chain Analysis
12.2 Recombinant Humanized Collagen Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Humanized Collagen Production Mode & Process
12.4 Recombinant Humanized Collagen Sales and Marketing
12.4.1 Recombinant Humanized Collagen Sales Channels
12.4.2 Recombinant Humanized Collagen Distributors
12.5 Recombinant Humanized Collagen Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Humanized Collagen Industry Trends
13.2 Recombinant Humanized Collagen Market Drivers
13.3 Recombinant Humanized Collagen Market Challenges
13.4 Recombinant Humanized Collagen Market Restraints
14 Key Findings in The Global Recombinant Humanized Collagen Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer